BackImmunovant Overview
Immunovant Inc

Immunovant Target Price

Immunovant target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$35.15

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-21H.C. WainwrightDouglas Tsao$4013.8% upsideOpen
2026-01-06Wolfe Research$5042.2% upsideOpen
2025-12-18GuggenheimYatin Suneja$4116.6% upsideOpen
2025-10-14Truist Financial$1654.5% downsideOpen
2024-09-10H.C. WainwrightDouglas Tsao$5145.1% upsideOpen
2024-06-03OppenheimerLeland Gershell$4630.9% upsideOpen
2024-05-30GuggenheimYatin Suneja$4836.6% upsideOpen
2024-05-30Piper SandlerYasmeen Rahimi$5762.2% upsideOpen
2024-03-13Goldman SachsCorinne Johnson$5042.2% upsideOpen
2022-09-26UBSColin Bristow$585.8% downsideOpen

Immunovant (IMVT) FAQ

Stockcircle tracks target price for Immunovant (IMVT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Immunovant's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main IMVT overview so you can move from this figure to the surrounding analysis quickly.